4//SEC Filing
Stolz Brian M. 4
Accession 0000899243-19-027434
CIK 0001743881other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 7:23 PM ET
Size
9.7 KB
Accession
0000899243-19-027434
Insider Transaction Report
Form 4
Stolz Brian M.
Chief Operating Officer
Transactions
- Award
Common Stock
2019-11-13+22,839→ 22,839 total - Award
Stock Option (Right to Buy)
2019-11-13+102,081→ 102,081 totalExercise: $26.28Exp: 2029-11-12→ Common Stock (102,081 underlying) - Award
Restricted Stock Units
2019-11-13+106,469→ 106,469 total→ Common Stock (106,469 underlying)
Footnotes (3)
- [F1]The option shall vest and become exercisable as to 25% of the shares on October 7, 2020, and as to 1/48th of the shares each month thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
- [F2]Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date.
- [F3]The units shall vest as to 25% of the units on November 16, 2020, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001524803
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 7:23 PM ET
- Size
- 9.7 KB